AMR Task Force

AMR Task Force Advisory Board

Helen W. Boucher, MD FACP FIDSA, Chief, Division of Geographic Medicine and Infectious Diseases; Director, Heart Transplant and Ventricular Assist Device Infectious Diseases Program; Tufts Medical Center; Director, Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR)

Jonathan Daniels, Senior Manager, Policy & Advocacy, Cystic Fibrosis Foundation

Greg Frank, Director, Global Public Policy, Merck

Phyllis E. Greenberger, MSW, Senior Vice President of Science & Health Policy, HealthyWomen

Nicholas Harrison, MPH, MA, Senior Policy Analyst, Duke-Margolis

Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America

Brett McReynolds, Vice President, Programs and Public Policy at the Autoimmune Association

Jewel Mullen, MD, MPH, Associate Dean for Health Equity, Associate Professor, Department of Population Health, the University of Texas at Austin, Dell Medical School

Kevin Outterson, Founder and Executive Director, CARB-X; Professor, Boston University School of Law

John Rex, Chief Medical Officer, F2G Limited; Founder, AMR.Solutions

Kristin Schneeman, Director, FasterCures, a Center of the Milken Institute

Monika Schneider, PhD, Director, Global Antimicrobial Resistance Policy, Shionogi

Kenneth E. Thorpe, PhD, Chairman, Partnership to Fight Chronic Disease, Robert W. Woodruff Professor and Chair, Department of Health Policy & Management, Rollins School of Public Health, Emory University

Jocelyn Ulrich, MPH, Deputy Vice President, Policy, Research and Membership, PhRMA